Abstract
The effect of morphine tolerance and withdrawal on prodynorphin peptides was studied in relevant brain areas and in the pituitary gland of male Sprague-Dawley rats, and compared with effects on the proenkephalin-derived peptide Met-enkephalin. After 8 days of morphine injections (twice daily), dynorphin A and B levels increased in the nucleus accumbens and dynorphin A levels increased also in the striatum. Morphine treatment increased striatal Met-enkephalin. Leu-enkephalinArg6 levels were reduced in the ventral tegmental area (VTA). Morphine-treated rats had very low Leu-enkephalinArg6 levels in the hippocampus as compared to saline control rats. Comparison of the relative amounts of dynorphin peptides and the shorter prodynorphin-derived peptides, Leu-enkephalinArg6 and Leu-enkephalin, revealed a relative increase in dynorphin peptides versus shorter fragments in the nucleus accumbens, VTA and hippocampus. Morphine-tolerant rats had lower levels of dynorphin A in both lobes of the pituitary gland, whereas hypothalamic dynorphin levels were unaffected by morphine. Leu-enkephalinArg6 levels were reduced in the hypothalamus, but not changed in the pituitary gland. Naloxone-precipitated withdrawal accentuated the increase in dynorphin A and B levels in the accumbens and dynorphin A levels in the striatum, while inducing an increase in enkephalin levels in the accumbens and Met-enkephalin in the VTA. In the hippocampus, Leu-enkephalinArg6 levels remained low in the withdrawal state. The low dynorphin levels in the anterior part of the pituitary gland were reversed by naloxone, whereas the low dynorphin A levels in the neurointer-mediate lobe were even lower in the withdrawal state. In conclusion, morphine tolerance and withdrawal affected prodynorphin-derived peptides in areas related to central reward mechanisms, and in the pituitary gland. The dynorphin peptides and the LeuenkephalinArg6 fragment were not affected similarly, indicating an effect also on metabolic interconversion.
Similar content being viewed by others
References
Aceto MD, Dewey WL, Chang J-K, Lee NM (1982) Dynorphin-(1–13): effects in non-tolerant and morphine-dependent rhesus monkeys. Eur J Pharmacol 83:139–142
Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF, Liebeskind JC (1992) The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575:304–308
Bergström L, Christensson I, Folkesson R, Stenström B, Terenius L (1983) An ion-exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P. Life Sci 33:1613–1619
Brechara A, Van der Kooy D (1987) Kappa receptors mediate the peripheral aversion effects of opiates. Pharmacol Biochem Behav 28:227–233
Chavkin C, Bakhit C, Weber E, Bloom FE (1983) Relative contents and concomitant release of prodynorphin/neo-endorphin-derived peptides rat hippocampus. Proc Natl Acad Sci USA 80:7669–7673
Chavkin C, Shoemaker WJ, McGinty JF, Bayon A, Bloom FE (1985) Characterization of the prodynorphin and proenkephalin systems in the rat hippocampus. J Neurosci 5:808–816
Childers S, Simantov R, Snyder SH (1977) Enkephalin: radioimmunoassay and receptorassay in morphine dependent rats. Eur J Pharmacol 46:289–295
Christensson-Nylander I, Nyberg F, Ragnarson U, Terenius L (1985) A general procedure for analysis of proenkephalin B derived opioid peptides. Regul Pept 11:65–76
Christensson-Nylander I, Herrera-Marschitz M, Staines W, Hökfelt T, Terenius L, Ungerstedt U, Cuello C, Oertel WH, Goldstein M (1986) Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Exp Brain Res 64:169–192
DiChiara G, Imperato A (1988a) Drugs abused by humans preferentially increase dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278
DiChiara G, Imperato A (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080
Engber TM, Boldry RC, Kuo S, Chase TN (1992) Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res 582:261–268
Fratta W, Yang H-Y T, Hong J, Costa E (1977) Stability of Metenkephalin content in brain structures of morphine dependent or foot-shock stressed rats. Nature 268:452–453
Friedman HJ, Jen M-F, Chang JK, Lee NM, Loh HH (1981) Dynorphin: a possible modulatory peptide on morphine or betaendorphin analgesia in mouse. Eur J Pharmacol 69:357–360
Green PG, Lee NM (1988) Dynorphin A-(1–13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur J Pharmacol 145:267–272
Gudehithlu KP, Tejwani GA, Bhargava HN (1991)β-Endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine-tolerant and abstinent rats. Brain Res 553:284–290
Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U (1986) Striatonigral dynorphin and substance P pathways in the rat. II: functional analysis. Exp Brain Res 64:193–207
Ho WKK, Wan CC, Chan WY, Cheung WK, Kwok KY, Wen HL (1982) Morphine addiction does not alter brain or pituitary immuno-reactive dynorphin levels. Pharm Res Commun 14:861–866
Hurd Y, Herkenham M (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol Brain Res 16:97–104
Khazan N, Young GA, Calligaro D (1983) Self-administration of dynorphin-(1–13) andD-Ala2-dynorphin-(1–11) (kappa opioid agonists) in morphine (mu-agonist)-dependent rats. Life Sci 33:559–562
Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:723–725
Kosterlitz HW, Hughes J (1975) Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci 17:91–96
Lason W, Przewlocka B, Przewlocki R (1992) The effects of excitatory amino acids on proenkephalin and prodynorphin mRNA levels in the hippocampal dentate gyrus of the rat; an in situ hybridization study. Mol Brain Res 12:243–247
Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA, Hong JS (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Mol Brain Res 8:219–225
Lutfy K, Hurlbut DE, Weber E (1993) Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res 616:83–88
McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE (1983) Dynorphin is contained within hippocampal mossy fibers: immunohistochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci USA 80:589–593
Millan MJ, Millan MH, Herz A (1983a) The contribution of the supraoptical nucleus to brain and pituitary pools of vasopressin and particular opioid peptides and the interrelationship between these in the rat. Neuroendocrinology 36:310–319
Millan MH, Millan MJ, Herz A (1983b) The hypothalamic paraventricular nucleus: relationship to brain and pituitary pools of vasopressin and oxytocin as compared to dynorphin,β-endorphin and related opioid peptides in the rat. Neuroendocrinology 38:108–166
Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280
Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439–2450
Nyberg F, Nordström K, Terenius L (1985) Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acids. Biochem Biophys Res Commun 131:1069–1074
Nylander I, Terenius L (1987) Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways. Neuropharmacology 26:1295–1302
Nylander I, Sakurada TS, LeGreves P, Terenius L (1991) Levels of dynorphin peptides, substance P and CGRP in the spinal cord after subchronic administration of morphine in the rat. Neuropharmacology 30:1219–1223
Ohno M, Yamamoto T, Araki H, Ueki S (1987) The effect ofκ-opioid agonist U 50,488H on wet-dog shaking behavior induced by hippocampal stimulation in rats. Psychopharmacology 91:189–192
Olson GA, Olson RD, Kastin AJ, Coy DH (1982) Endogenous opiates: 1981. Peptides 3:1039–1072
Olson GA, Olson RD, Kastin AJ (1992) Endogenous opiates: 1991. Peptides 13:1247–1287
Persson S, Post C, Alari L, Nyberg F, Terenius L (1989) Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats. Neurosci Lett 107:318–322
Pickel VM, Chan J, Sesack SR (1993) Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res 602:275–289
Rattan AK, Koo KL, Tejwani GA, Bhargava HN (1992) The effect of morphine tolerance, dependence and abstinence on immunoreactive dynorphin(1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res 584:207–212
Romualdi P, Lesa G, Ferri S (1991) Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Res 563:132–136
Schmauss C, Herz A (1987) Intrathecally administered dynorphin-(1–17) modulates morphine-induced antinociception differently in morphine-naive and morphine-dependent rats. Eur J Pharmacol 135:429–431
Seizinger BR, Höllt V, Herz A (1981a) Evidence for the occurrence of the opioid octapeptide dynorphin-(1–8) in the neurointermediate pituitary of rats. Biochem Biophys Res Commun 102:197–205
Seizinger BR, Höllt V, Herz A (1981b) Immunoreactive dynorphin in the rat adenohypophysis consists exclusively of 6000 dalton species. Biochem Biophys Res Commun 103:256–263
Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734–1739
Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046–2050
Stevens KE, Shiotsu G, Stein L (1991) Hippocampalμ-receptors mediate opioid reinforcement in the CA3 region. Brain Res 545:8–16
Takemori AE, Loh HH, Lee NM (1992) Suppression by dynorphin A-(1–13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol 221:296–298
Trujillo KA, Akil H (1989) Changes in prodynorphin peptide content following treatment with morphine or amphetamine: possible role in mechanisms of action of drug abuse. NIDA Res Monogr 95:550–551
Trujillo KA, Day R, Akil H (1990) Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res 518:244–256
Trujillo KA, Akil H (1994) Inhibition of opiate tolerance by noncompetitiveN-methyl-D-aspartate receptor antagonists. Brain Res 633:178–188
Tulunay FC, Jen MF, Chang JK, Loh HH, Lee NM (1981) Possible regulatory role of dynorphin on morphine and beta-endorphin-induced analgesia. J Pharmacol Exp Ther 219:296–298
Uhl GR, Ryan JP, Schwartz JP (1988) Morphine alters preproenkephalin gene expression. Brain Res 459:391–397
Unterwald EM, Tempel A, Koob GF, Zukin S (1989) Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions. Brain Res 505:111–118
Vlaskovska M, Geijer T, Nylander I, Silberring J, Terenius L (1994) Changes in the prodynorphin system after chronic morphine treatment vitro. Regul Pept Suppl. 1:S287-S288
Wagner JJ, Terman GW, Chavkin C (1993) Endogenous dynorphins inhibit neurotransmission and block LTP induction in the hippocampus. Nature 363:451–454
Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362:423–427
Weissman BA, Zamir N (1987) Differential effects of heroin on opioid levels in the rat brain. Eur J Pharmacol 139:121–123
Wen HL, Ho WKK (1982) Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur J Pharmacol 82:183–186
Wesche D, Höllt V, Herz A (1977) Radioimmunoassay of enkephalins. Regional distribution in rat brain after morphine treatment and hypophysectomy. Naunyn-Schmiedebergs Arch Pharmacol 301:79–82
Wise RA (1989) Opiate reward: sites and substrates. Neurosci Biobehav Rev 13:129–133
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492
Yukhananov RY, Zhai QZ, Persson S, Post C, Nyberg F (1993) Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens. Neuropharmacology 32:703–709
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nylander, I., Vlaskovska, M. & Terenius, L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in sprague-dawley rats. Psychopharmacology 118, 391–400 (1995). https://doi.org/10.1007/BF02245939
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245939